New guidelines issued for biopsy use in melanoma patients
(HealthDay) -- Sentinel lymph node biopsy -- a minimally invasive surgical technique that lets doctors see whether cancer has spread -- should be performed on patients with melanoma tumors of intermediate ...
Cancer
Jul 09, 2012 |
not rated yet |
0
Scientists find molecule in immune system that could help treat dangerous skin cancer
Researchers from Brigham and Women's Hospital (BWH) have made a groundbreaking discovery that will shape the future of melanoma therapy. The team, led by Thomas S. Kupper, MD, chair of the BWH Department of Dermatology, and ...
Immunology
Jul 08, 2012 |
5 / 5 (1) |
0
|
Early childhood neglect may raise risk of adult skin cancer
Skin cancer patients whose childhood included periods of neglect or maltreatment are at a much greater risk for their cancers to return when they face a major stressful event, based on a new study.
Psychology & Psychiatry
Jun 04, 2012 |
4 / 5 (4) |
0
|
ASCO: Dabrafenib/Trametinib active in metastatic melanoma
(HealthDay) -- For patients with V600 BRAF-mutant solid tumors, treatment with the oral BRAF inhibitor dabrafenib and the oral MEK 1/2 inhibitor trametinib is tolerated and has clinical activity in BRAF inh ...
Cancer
May 17, 2012 |
not rated yet |
0
RNA regulator of melanoma could be a new target for cancer therapy
Melanoma is the most deadly form of skin cancer, estimated by the National Cancer Institute to afflict more than 70,000 people in the United States annually and the incidence rate continues to rise. In a study published online ...
Cancer
May 10, 2012 |
5 / 5 (1) |
0
|
Eye color may indicate risk for serious skin conditions
Eye color may be an indicator of whether a person is high-risk for certain serious skin conditions. A study, led by the University of Colorado School of Medicine, shows people with blue eyes are less likely to have vitiligo. ...
Genetics
May 06, 2012 |
4.6 / 5 (10) |
0
|
Outwitting a brainy gene
(Medical Xpress) -- The very first in the series of mutations causing colon cancer occurs in the beta-catenin gene; this gene is abnormally activated in about 90 percent of colorectal cancer patients, and in a much smaller ...
Cancer
May 01, 2012 |
5 / 5 (2) |
0
Researchers creating "designer lymph nodes"
Researchers at Moffitt Cancer Center are in the first phase of creating "designer lymph nodes." Designer lymph nodes are built with specialized gene-modified cells that are injected into patients and produce a pre-planned ...
Genetics
Apr 29, 2012 |
5 / 5 (3) |
0
|
Study reveals trigger that may speed melanoma growth
(HealthDay) -- Growth of the deadly skin cancer melanoma may be triggered by the immune system turning on itself, according to a new study that also identified the mechanism that causes this to happen.
Cancer
Mar 28, 2012 |
5 / 5 (3) |
0
|
Researchers building melanoma vaccine to combat skin cancer
Mayo Clinic researchers have trained mouse immune systems to eradicate skin cancer from within, using a genetic combination of human DNA from melanoma cells and a cousin of the rabies virus. The strategy, called cancer immunotherapy, ...
Cancer
Mar 19, 2012 |
5 / 5 (11) |
0
|
Researchers report progress in cancer immunotherapy
In a bid to make cancer immunotherapy more effective, researchers report they have succeeded in halting the progress of aggressive melanoma in its tracks - at least briefly - in seven patients treated with an army of cloned ...
Cancer
Mar 06, 2012 |
5 / 5 (3) |
0
The loss of a protein makes 'jump' the tumor to the lymph node
Metastasis is responsible for 90% of deaths in patients with cancer. Understanding the mechanisms responsible for this process is one of the top goals of cancer research. The metastatic process involves a series of steps ...
Cancer
Mar 06, 2012 |
5 / 5 (3) |
0
Using patients' own tumor-fighting cells to knock back advanced melanoma
A small, early-phase clinical trial to test the effectiveness of treating patients with advanced melanoma using billions of clones of their own tumor-fighting cells combined with a specific type of chemotherapy has shown ...
Cancer
Mar 05, 2012 |
4.8 / 5 (5) |
0
|
Researchers find potential solution to melanoma's resistance to vemurafenib
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
Cancer
Feb 28, 2012 |
not rated yet |
0
|
Dose-Response link between tanning bed use, skin cancer
(HealthDay) -- Use of tanning beds, especially in high school and college, is associated with an increased risk of skin cancer, according to a study published online Feb. 27 in the Journal of Clinical Oncology.
Cancer
Feb 28, 2012 |
5 / 5 (1) |
0
